- Видео 239
- Просмотров 19 724
OncologyTube
США
Добавлен 16 мар 2017
OncologyTube produces, finds and distributes videos and other content related to the education and information for oncologists.
ASCO 2024 Top 3 Practice Changing Head & Neck Cancer Studies
Subscribe to OncologyTube eNewsletter: share.hsforms.com/1dpwSptdCQP6Sq3WaY60Shg29pxh
ASCO 2024 Highlights on Practice-Changing Head & Neck Cancer Studies by Dr. Shlomo Koyfman
IMRT vs. IMPT (Proton Therapy) Phase III Study:
Objective: Compare intensity-modulated radiotherapy (IMRT) with intensity-modulated proton therapy (IMPT) for head and neck cancer.
Findings: Cure rates and efficacy are comparable between IMRT and IMPT. Proton therapy significantly reduces the need for feeding tubes and duration of use.
Impact: Confirms the precision of proton therapy and its ability to reduce side effects, potentially changing the standard of care.
F MISO Biomarker Trial (Nancy Lee, Sloan Kettering):
Objec...
ASCO 2024 Highlights on Practice-Changing Head & Neck Cancer Studies by Dr. Shlomo Koyfman
IMRT vs. IMPT (Proton Therapy) Phase III Study:
Objective: Compare intensity-modulated radiotherapy (IMRT) with intensity-modulated proton therapy (IMPT) for head and neck cancer.
Findings: Cure rates and efficacy are comparable between IMRT and IMPT. Proton therapy significantly reduces the need for feeding tubes and duration of use.
Impact: Confirms the precision of proton therapy and its ability to reduce side effects, potentially changing the standard of care.
F MISO Biomarker Trial (Nancy Lee, Sloan Kettering):
Objec...
Просмотров: 50
Видео
ASCO 2024 Top 5 Myeloid Neoplasm Risk Score Questions From A 1 Million Patient Trial
Просмотров 110Месяц назад
Timecodes: 0:00 - Intro 0:19 - What are the most significant predictors of therapy-related myeloid neoplasms (tMNs) identified in your study, and how were these incorporated into the tMN risk score (TMNRS)? 1:48 - Can you discuss the methodology used for developing and validating the TMNRS, including the use of the SEER-Medicare database and the Χ2 test for identifying risk factors? 3:51 - How ...
How Does Isatuximab (SARCLISA) - VRd Improve PFS in Transplant-Ineligible NDMM Patients? ASCO 2024
Просмотров 32Месяц назад
Improved PFS in treatment of multiple myeloma, a multi-clonal disease, by incorporating Isatuximab into the VRD regimen. Dr. Zandra Klippel, MD - Global Product Head of Isatuximab at SANOFI discusses how targeting multiple mechanisms of action can lead to significantly better outcomes for patients. 🔬 Key Highlights: Mechanism of Action: The addition of Isatuximab to VRD enhances both depth of r...
ASCO 2024 Top 5 Pembrolizumab vs. Chemotherapy for Sarcoma Questions
Просмотров 125Месяц назад
Dr. Yvonne Mowery, MD of UPMC Hillman Cancer Center presents the latest findings from a pivotal clinical trial comparing Pembrolizumab to chemotherapy in the treatment of stage III soft tissue sarcoma. Filmed at ASCO 2024, this update dives into the critical results, including disease-free survival (DFS) and overall survival (OS) data after a median follow-up of three years. In this video, we p...
ASCO 2024 Top 5 SARCLISA Isatuximab + VRd Phase 3 IMROZ Multiple Myeloma Questions
Просмотров 164Месяц назад
Jump to the Answer: 0:00 - I think Multiple Myeloma is a Multi-Clonial Disease 0:10 - Efficacy: Isa-VRd vs. VRd: What mechanisms improve progression-free survival (PFS) with Isa-VRd, and how does this impact treatment for transplant-ineligible NDMM patients? 01:04 - Impact on Treatment Duration: The median treatment duration was significantly longer in the Isa-VRd arm compared to VRd alone. How...
ASCO 2024 Top 5 Zanidatamab Phase 2 HER2+ Questions on Biliary Tract Cancer
Просмотров 91Месяц назад
Dr. Shubham Pant presents the latest updates from the Phase 2 trial of zanidatamab, a bispecific HER2 antibody, in patients with HER2 biliary tract cancer (BTC) HERIZON-BTC-01. More Details Here: 🔬 HERIZON-BTC-01 Study Highlights: Mechanism of Action: Zanidatamab binds to two domains on the HER2 protein (ECD2 and ECD4), leading to better receptor internalization and HER2 downregulation, enhanci...
Phase 2 Outreach Study: CAR T-Cell Therapy in Community & University Settings - Yuliya Linhares, MD
Месяц назад
Phase 2 Outreach study, which evaluates the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy, specifically lysocaptogene maraleucel (liso-cel), in patients with relapsed or refractory large B-cell lymphoma across both outpatient and inpatient settings at community and university sites in the United States. More Details Here: oncologytube.com/liso-cel-ash-2022-yuliya-linhare...
ASCO 2024 Phase 3 IMROZ Results Evaluating Sarclisa (Isatuximab) + VRd in Transplant-Ineligible NDMM
Просмотров 120Месяц назад
Dr. Zandra Klippel summarizes Phase 3 results from the IMROZ study at ASCO 2024. This study evaluates the efficacy of Sarclisa (isatuximab) in combination with VRd (bortezomib, lenalidomide, and dexamethasone) in patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for transplant. More Details and Links Here: oncologytube.com/asco-2024-phase-3-imroz-study-sarclisa-isatuximab...
ASCO 2024 Palbociclib, Pembrolizumab & Endocrine Therapy: Outcomes & Gut Microbiome in HR+/HER2- MBC
Просмотров 153Месяц назад
Dr. Alexis LeVee from City of Hope presents innovative findings from a Phase 1b clinical trial combining CDK4/6 inhibitors with PD-1 inhibitors for hormone receptor-positive, HER2-negative metastatic breast cancer. This study explores the potential of palbociclib, pembrolizumab, and endocrine therapy to enhance anti-tumor responses and improve clinical outcomes. More Details and Link to Abstrac...
ASCO 2024: Impact of Latino Ethnicity on Gut Microbiome in mRCC Regina Barragan-Carillo, Phd
Просмотров 49Месяц назад
📺 Description: Welcome to our latest video from the ASCO 2024 conference! In this presentation, Dr. Regina Barragan-Carillo from Cedar Folk Comprehensive Cancer Center discusses her groundbreaking research on the impact of Latino ethnicity on the gut microbiome composition in patients with metastatic renal cell carcinoma. 🔬 Study Highlights: Objective: To determine how Latino ethnicity affects ...
ASCO 2024 - High-Dose Chemotherapy for Recurrent Germ Cell Tumors: Hedyeh Ebrahimi, MD
Просмотров 57Месяц назад
Join us as Dr. Hedyeh Ebrahimi from City of Hope presents a groundbreaking study led by Dr. Alex Chehrazi Rafel at the ASCO 2024 conference. This collaborative research involved four referral centers: City of Hope, UCSF, UC Davis, and UCLA, and focused on high-dose chemotherapy treatments for recurrent germ cell tumors. See the poster here: oncologytube.com/high-dose-chemotherapy-for-recurrent-...
ASCO 2024 Top 5 Kidney & Bladder Cancer Trials | Monty Pal, MD City of Hope
Просмотров 83Месяц назад
Ahead of ASCO 2024 Monty Pal, MD of City of Hope goes over the top 5 must see abstracts, presentations and data. For links to the trials click here: oncologytube.com/monty-pal-md-top-5-asco-2024-kidney-bladder-cancer-must-see-presentations/
ASCO 2024 Top 5 Melanoma & Immunotherapy Abstracts with Omid Hamid, MD
Просмотров 865Месяц назад
Dr. Omid Hamid, MD outlines his favorite ASCO 2024 presentations that will be presented. Should they be on your short list? To view the links click over to OncologyTube.com at this link: oncologytube.com/asco-2024-top-5-presentations-to-see-from-omid-hamid-md/
ASCO 2021 Highlights in Lung Cancer Jack West, MD
Просмотров 2603 года назад
ASCO 2021 Highlights in Lung Cancer Jack West, MD
ASCO 2021 Highlights in Breast Cancer Aditya Bardia, MD
Просмотров 1503 года назад
ASCO 2021 Highlights in Breast Cancer Aditya Bardia, MD
ASCO 2021 Highlights in Colorectal Cancer and Gastrointestinal Cancer David Illson, MD
Просмотров 5293 года назад
ASCO 2021 Highlights in Colorectal Cancer and Gastrointestinal Cancer David Illson, MD
Special Edition ASCO 2021 Highlights RoundTable Discussion
Просмотров 843 года назад
Special Edition ASCO 2021 Highlights RoundTable Discussion
Top 5 ASCO 2021 Abstracts - Gastrointestinal Cancer
Просмотров 4963 года назад
Top 5 ASCO 2021 Abstracts - Gastrointestinal Cancer
Never-before-seen Antibody Binding, Informing Both Liver Cancer And Antibody Design
Просмотров 513 года назад
Never-before-seen Antibody Binding, Informing Both Liver Cancer And Antibody Design
Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic-Racial Groups
Просмотров 253 года назад
Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic-Racial Groups
TRANSFORMER: A Randomized Phase II Study - Prostate Cancer
Просмотров 523 года назад
TRANSFORMER: A Randomized Phase II Study - Prostate Cancer
Acceptance and Priority Review Of sNDA For Ruxolitinib As A Treatment For Patients With cGVHD
Просмотров 483 года назад
Acceptance and Priority Review Of sNDA For Ruxolitinib As A Treatment For Patients With cGVHD
How Inflammatory Signaling Molecules Contribute To Carcinogenesis
Просмотров 303 года назад
How Inflammatory Signaling Molecules Contribute To Carcinogenesis
Martin S. Tallman, MD, Begins Term as 2021 ASH President
Просмотров 833 года назад
Martin S. Tallman, MD, Begins Term as 2021 ASH President
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes
Просмотров 93 года назад
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes
Evaluation Of A Novel Blood Pressure Scoring Method
Просмотров 543 года назад
Evaluation Of A Novel Blood Pressure Scoring Method
Survival of patients with deficient mismatch repair mCRC in the pre-immunotherapy era
Просмотров 203 года назад
Survival of patients with deficient mismatch repair mCRC in the pre-immunotherapy era
Randomized phase 2 trial of pevonedistat
Просмотров 333 года назад
Randomized phase 2 trial of pevonedistat
I hope that someone will encourage Dr. Weber to give some youtube-available talk on the latest cancer vaccine data from Moderna. It's currently hidden behind ASCO's paywall.
Hi @jonetyson thank you for the comment. Are there other channels that are providing this type of information on RUclips or no? I'm not sure if there is a way to private message here but I would like to hear more about what you are looking for in an interview. Maybe we can make that happen. Email me at allen@oncologytube.com if you would like to chat.
Thank you for the Like!
Quad combo sounds like lots of financial toxicities.
Thank you for the comment!
'promosm'
At first never really believe I could be cured by a herbal remedy until I met this great herbal practitioner dr Harvey.. This is a great great testimony l have to share with all CANCER patients in the world.I never believed that there could be a complete cure for CANCER of any kind, I saw people's testimony on blogs about how DR Harvey Prepared ROOTS and HERBS from AFRICA and it brought them back to good health again. I had to try it too. You won't believe that in less than 2 weeks I started using it as directed by him, the lung Cancer Virus vanished gradually and I had to live without CANCER DRUGS, which the doctor gave me. Right now l can tell you that for a few months now, I have not experience any pain or outbreak also confirmed Negative .. Delay in treatment causes great HARM when detected lately and may sometimes lead to death.Please don’t take your health for granted. Dr Harvey,a herbal practitioner and phytotherapist cure cancer permanently with his natural herbal remedies called propolis lecithin Capsules.contact Dr. Harvey via WhatsApp;+1 (475) 522‑1289